Would you consider giving neoadjuvant therapy using a KEYNOTE-522 regimen to someone with cT1c cN0 TNBC?  

How would you proceed given that cT1c didn't meet the study criteria? 

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist at Albert Einstein College of Medicine/Montefiore Health System
Thank you! 
Sign in or Register to read more